Free Trial

Guardion Health Sciences Q1 2023 Earnings Report

Guardion Health Sciences EPS Results

Actual EPS
$0.42
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Guardion Health Sciences Revenue Results

Actual Revenue
$3.19 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Guardion Health Sciences Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Guardion Health Sciences Earnings Headlines

Elon Musk: my AI will be “worth more than Tesla”
Tesla made Elon Musk the richest man in human history. And now, Elon's got a new AI project...
Guardion Health Sciences Inc (GHSI)
See More Guardion Health Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Guardion Health Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardion Health Sciences and other key companies, straight to your email.

About Guardion Health Sciences

Guardion Health Sciences (NASDAQ:GHSI), a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

View Guardion Health Sciences Profile

More Earnings Resources from MarketBeat